Principles for Valid Histopathologic Scoring in Research

Veterinary Pathology

Volumn 50, Issue 6, 2013, Pages 1007-1015

  Gibson Corley, K N ^a   Olivier, A K ^a   Meyerholz, D K ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

grading; histopathology; lesions; ordinal; scoring; semiquantitative; validation

Indexed keywords

ANIMAL; DISEASE MODEL; METHODOLOGY; PATHOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; STANDARDS; VALIDATION STUDY;

ANIMALS; DISEASE MODELS, ANIMAL; PATHOLOGY; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; VALIDATION STUDIES AS TOPIC;

EID: 84887527334     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985813485099     Document Type: Article

References (76)

1. Begley CG,Ellis LM.Raise standards for preclinical cancer research.Nature. 2012;483:531-533.
2. Bleich A,Mahler M,Most C, et al.Refined histopathologic scoring system improves power to detect colitis QTL in mice.Mamm Genome. 2004;15:865-871.
3. Brayton CF,Justice M,Montgomery CA.Evaluating mutant mice: anatomic pathology.Vet Pathol. 2001;38:1-19.
4. Brayton CF,Treuting PM,Ward JM.Pathobiology of aging mice and GEM: background strains and experimental design.Vet Pathol. 2012;49:85-105.
5. Brisson AR,Matsui D,Rieder MJ, et al.Translational research in pediatrics: tissue sampling and biobanking.Pediatrics. 2012;129:1-10.
6. Brown AT,Ou X,James LP, et al.Correlation of MRI findings to histology of acetaminophen toxicity in the mouse.Magn Reson Imaging. 2012;30:283-289.
7. Bucci TJHandbook of Toxicologic Pathology. 2nd ed. Vol. 1. San Diego, CA: Academic Press; 2002:171-185.Haschek WMRousseaux CGWallig MA, ed. San Diego, CA: Academic Press; 2002:171-185.
8. Burkhardt JE,Pandher K,Solter PF, et al.Recommendations for the evaluation of pathology data in nonclinical safety biomarker qualification studies.Toxicol Pathol. 2011;39:1129-1137.
9. Cake MA,Smith MM,Young AA, et al.Synovial pathology in an ovine model of osteoarthritis: effect of intraarticular hyaluronan (Hyalgan).Clin Exp Rheumatol. 2008;26:561-567.
10. Cheng Z,Dhall D,Zhao L, et al.Murine model of Hirschsprung-associated enterocolitis, I: phenotypic characterization with development of a histopathologic grading system.J Pediatr Surg. 2010;45:475-482.
11. Crawford JM,Tykocinski ML.Pathology as the enabler of human research.Lab Invest. 2005;85:1058-1064.
12. Crissman JW,Goodman DG,Hildebrandt PK, et al.Best practices guideline: toxicologic histopathology.Toxicol Pathol. 2004;32:126-131.
13. Cross SS.Grading and scoring in histopathology.Histopathology. 1998;33:99-106.
14. Cross SS.Kappa statistics as indicators of quality assurance in histopathology and cytopathology.J Clin Pathol. 1996;49:597-599.
15. Day SJ,Altman DG.Statistics notes: blinding in clinical trials and other studies.Br Med J. 2000;321:504.
16. De Cock HE,Forman MA,Farver TB, et al.Prevalence and histopathologic characteristics of pancreatitis in cats.Vet Pathol. 2007;44:39-49.
17. Eaton KA,Danon SJ,Krakowka S, et al.A reproducible scoring system for quantification of histologic lesions of inflammatory disease in mouse gastric epithelium.Comp Med. 2007;57:57-65.
18. Ettreiki C,Gadonna-Widehem P,Mangin I, et al.Juvenile ferric iron prevents microbiota dysbiosis and colitis in adult rodents.World J Gastroenterol. 2012;18:2619-2629.
19. Ferguson AR,Hook MA,Garcia G, et al.A simple post hoc transformation that improves the metric properties of the BBB scale for rats with moderate to severe spinal cord injury.J Neurotrauma. 2004;21:1601-1613.
20. Festing MFW.Design and statistical methods in studies using animal models of development.ILAR J. 2006;47:5-14.
21. Festing MFW,Altman DG.Guidelines for the design and statistical analysis of experiments using laboratory animals.ILAR J. 2002;43:244-258.
22. Gad SCStatistics and Experimental Design for Toxicologists and Pharmacologists. Boca Raton, FL: CRC Press; 2006:.
23. Gauger PC,Vincent AL,Loving CL, et al.Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus.Vet Pathol. 2012;49:900-912.
24. Germolec DR,Nyska A,Kashon M, et al.Extended histopathology in immunotoxicity testing: interlaboratory validation studies.Toxicol Sci. 2004;78:107-115.
25. Gerwin N,Bendele AM,Glasson S, et al.The OARSI histopathology initiative: recommendations for histological assessments of osteoarthritis in the rat.Osteoarthritis Cartilage. 2010;18 (suppl 3): S24-S34.
26. Gholamiandehkordi AR,Timbermont L,Lanckriet A, et al.Quantification of gut lesions in a subclinical necrotic enteritis model.Avian Pathol. 2007;36:375-382.
27. Gibson-Corley KN,Hochstedler C,Sturm M, et al.Successful integration of the histology core laboratory in translational research.J Histotechnol. 2012;35:17-21.
28. Goddard CJ,Smith A,Hoyland JA, et al.Localisation and semiquantitative assessment of hepatic procollagen mRNA in primary biliary cirrhosis.Gut. 1998;43:433-440.
29. Grafe MR,Woodworth KN,Noppens K, et al.Long-term histological outcome after post-hypoxic treatment with 100% or 40% oxygen in a model of perinatal hypoxic-ischemic brain injury.Int J Dev Neurosci. 2008;26:119-124.
30. Holland T.The comparative power of the discriminant methods used in toxicological pathology.Toxicol Pathol. 2005;33:490-494.
31. Holland T,Holland C.Analysis of unbiased histopathology data from rodent toxicity studies (or, are these groups different enough to ascribe it to treatment?).Toxicol Pathol. 2011;39:569-575.
32. Hörnblad A,Cheddad A,Ahlgren U.An improved protocol for optical projection tomography imaging reveals lobular heterogeneities in pancreatic islet and β-cell mass distribution.Islets. 2011;3:204-208.
33. Hübner RH,Gitter W,El Mokhtari NE, et al.Standardized quantification of pulmonary fibrosis in histological samples.Biotechniques. 2008;44:507 514-511 517.
34. Isobe K,Adachi K,Hayashi S, et al.Spontaneous glomerular and tubulointerstitial lesions in common marmosets (Callithrix jacchus).Vet Pathol. 2012;49:839-845.
35. Jacobs PC,Prokop M,Oen AL, et al.Semiquantitative assessment of cardiovascular disease markers in multislice computed tomography of the chest: interobserver and intraobserver agreements.J Comput Assist Tomogr. 2010;34:279-284.
36. Jassal MS,Nedeltchev GG,Osborne J, et al.A modified scoring system to describe gross pathology in the rabbit model of tuberculosis.BMC Microbiol. 2011;11:49.
37. Kayser K,Schultz H,Goldmann T, et al.Theory of sampling and its application in tissue based diagnosis.Diagn Pathol. 2009;4:6.
38. Kitching AR,Katerelos M,Mudge SJ, et al.Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis.Clin Exp Immunol. 2002;128:36-43.
39. Kleiner DE,Brunt EM.Natta MV,et al,for the Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease.Hepatology. 2005;41:1313-1321.
40. Klesney-Tait J,Keck K,Li X, et al.Transepithelial migration of neutrophils into the lung requires TREM-1.J Clin Invest. 2013;123:138-149.
41. Kohlmann T,Moock JHandbooks: Statistics and Data Management. Stengal DBhandari MHanson B, ed. Davos, Switzerland: AO Publishing; 2009:93-110.
42. Lafemina MJ,Sheldon RA,Ferriero DM.Acute hypoxia-ischemia results in hydrogen peroxide accumulation in neonatal but not adult mouse brain.Pediatr Res. 2006;59:680-683.
43. Landis JR,Koch GG.The measurement of observer agreement for categorical data.Biometrics. 1977;33:159-174.
44. Langlois RA,Meyerholz DK,Coleman RA, et al.Oseltamivir treatment prevents the increased influenza virus disease severity and lethality occurring in chronic ethanol consuming mice.Alcohol Clin Exp Res. 2010;34:1425-1431.
45. Mann PC,Vahle J,Keenan CM, et al.International harmonization of toxicologic pathology nomenclature: an overview and review of basic principles.Toxicol Pathol. 2012;40:7S-13S.
46. Miao EA,Leaf IA,Treuting PM, et al.Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria.Nat Immunol. 2010;11:1136-1142.
47. Murthy S,Adamcakova-Dodd A,Perry SS, et al.Modulation of reactive oxygen species by Rac1 or catalase prevents asbestos-induced pulmonary fibrosis.Am J Physiol Lung Cell Mol Physiol. 2009;297:L846-L855.
48. Olivier AK,Naumann P,Goeken A, et al.Genetically modified species in research: opportunities and challenges for the histology core laboratory.J Histotechnol. 2012;35:63-67.
49. Pannucci CJ,Wilkins EG.Identifying and avoiding bias in research.Plast Reconstr Surg. 2010;126:619-625.
50. Pearson RG,Kurien T,Shu KSS, et al.Histopathology grading systems for characterisation of human knee osteoarthritis-reproducibility, variability, reliability, correlation, and validity.Osteoarthritis Cartilage. 2011;19:324-331.
51. Pinson DM,Schoeb TR,Lindsey JR, et al.Evaluation by scoring and computerized morphometry of lesions of early Mycoplasma pulmonis infection and ammonia exposure in F344/N rats.Vet Pathol. 1986;23:550-555.
52. Prinz F,Schlange T,Asadullah K.Believe it or not: how much can we rely on published data on potential drug targets?.Nat Rev Drug Discov. 2011;10:712.
53. Pritzker KP,Gay S,Jimenez SA, et al.Osteoarthritis cartilage histopathology: grading and staging.Osteoarthritis Cartilage. 2006;14:13-29.
54. Reproducible methods [editorial]. Nat Cell Biol. 2009;11:667.
55. Rollins KE,Meyerholz DK,Johnson GD, et al.A forensic investigation into the etiology of bat mortality at a wind farm: barotrauma or traumatic injury?.Vet Pathol. 2012;49:362-371.
56. Scheinin T,Butler DM,Salway F, et al.Validation of the interleukin-10 knockout mouse model of colitis: antitumour necrosis factor-antibodies suppress the progression of colitis.Clin Exp Immunol. 2003;133:38-43.
57. Schulz KF,Chalmers I,Hayes R, et al.Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials.JAMA. 1995;273:408.
58. Sellers RS.The Gene or not the gene-that is the question: understanding the genetically engineered mouse phenotype.Vet Pathol. 2012;49:5-15.
59. Shackelford C,Long G,Wolf J, et al.Qualitative and quantitative analysis of nonneoplastic lesions in toxicology studies.Toxicol Pathol. 2002;30:93-96.
60. Shott S.Statistics simplified: designing studies that answer questions.J Am Vet Med Assoc. 2011;238:55-58.
61. Shott S.Statistics simplified: detecting statistical errors in veterinary research.J Am Vet Med Assoc. 2011;237:305-308.
62. Shott S.Statistics simplified: wrapping it all up.J Am Vet Med Assoc. 2011;239:362-371.
63. Sica GT.Bias in research studies.Radiology. 2006;238:780-789.
64. Snider TA,Confer AW,Payton ME.Pulmonary histopathology of Cytauxzoon felis infections in the cat.Vet Pathol. 2010;47:698-702.
65. Steel RGD,Torrie JH,Dickey DAPrinciples and Procedures of Statistics: A Biomedical Approach. 3rd ed. Boston, MA: WCB McGraw-Hill; 1997:563-588.Steel RGDTorrie JHDickey DA, ed. Boston, MA: WCB McGraw-Hill; 1997:563-588.
66. Stevens SS.On the theory of scales of measurement.Science. 1946;103:677-680.
67. Strasak AM,Zaman Q,Pfeiffer KP, et al.Statistical errors in medical research-a review of common pitfalls.Swiss Med Wkly. 2007;137:44-49.
68. Thoolen B,Maronpot RR,Harada T, et al.Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system.Toxicol Pathol. 2010;38:5S-81S.
69. Timbermont L,Lanckriet A,Dewulf J, et al.Control of Clostridium perfringens-induced necrotic enteritis in broilers by target-released butyric acid, fatty acids and essential oils.Avian Pathol. 2010;39:117-121.
70. Torrence AE,Brabb T,Viney JL, et al.Serum biomarkers in a mouse model of bacterial-induced inflammatory bowel disease.Inflamm Bowel Dis. 2008;14:480-490.
71. Vascellari M,Giantin M,Capello K, et al.Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.Vet Pathol. 2013;50:110-121.
72. Venturi C,Sempoux C,Bueno J, et al.Novel histologic scoring system for long-term allograft fibrosis after liver transplantation in children.Am J Transplant. 2012;12:2986-2996.
73. Viera AJ,Garrett JM.Understanding interobserver agreement: the kappa statistic.Fam Med. 2005;37:360-363.
74. Wachtel MS,Shome G,Sutherland M, et al.Derivation and validation of murine histologic alterations resembling asthma, with two proposed histologic grade parameters.BMC Immunol. 2009;10:58.
75. Ward JM,Thoolen B.Grading of lesions.Toxicol Pathol. 2011;39:745-746.
76. Zeiss CJ,Ward JM,Allore HG.Designing phenotyping studies for genetically engineered mice.Vet Pathol. 2012;49:24-31.